BSX - Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices Stock Soars | Benzinga
Boston Scientific Corporation (NYSE:BSX) shares are trading higher on Wednesday after the company reported better-than-expected first-quarter earnings and issued guidance.
The company generated first-quarter revenues of $3.86 billion, beating the consensus estimate of $3.69 billion.
Sales soared 13.8% year-over-year on a reported basis, 15% on an operational basis, and 13.1% on an organic basis, beating the management guidance of approximately 7.5%-9.5% on a reported basis and approximately 7%-9% on an organic basis.
The company earned an adjusted EPS of ...